3 | SEC Filings Hub

Filing metadata

Accession number: 0001140361-22-002075
Form type: Form 3
Filer: Ernexa Therapeutics Inc.
CIK: CIK 748592
Filed: Jan 19, 2022
Reporting period: Jan 14, 2022
Description: Initial ownership

Documents

0001140361-22-002075-index.htm

Complete submission

0001140361-22-002075.txt

directory listing

Filed by

Ernexa Therapeutics Inc.